S. Fraser

发表

Emerging and alternative technologies

Rebecca M Crisino, S. Fraser, Mark Dysinger, 2016 .

2018 White Paper on Recent Issues in Bioanalysis: 'A global bioanalytical community perspective on last decade of incurred samples reanalysis (ISR)' (Part 1 - small molecule regulated bioanalysis, small molecule biomarkers, peptides & oligonucleotide bioanalysis).

Sam H Haidar, Gustavo Mendes Lima Santos, Nicola C Hughes, 2018, Bioanalysis.

Current practices and future outlook on the integration of biomarkers in the drug development process.

S. Fraser, Sarah Osgood, 2017, Bioanalysis.

2017 White Paper on recent issues in bioanalysis: a global perspective on immunogenicity guidelines & biomarker assay performance (Part 3 - LBA: immunogenicity, biomarkers and PK assays).

Sam H Haidar, Lauren F. Stevenson, Barry van der Strate, 2017, Bioanalysis.

Due diligence in the characterization of matrix effects in a total IL-13 Singulex™ method.

S. Fraser, C. Soderstrom, 2014, Bioanalysis.

When close is not close enough: a comparison of endogenous and recombinant biomarker stability samples.

S. Fraser, K. Ogborne, C. Fleener, 2015, Bioanalysis.

Association between serum interleukin‐17A and clinical response to tofacitinib and etanercept in moderate to severe psoriasis

H. Valdez, S. Fraser, C. Mebus, 2018, Clinical and experimental dermatology.

2016 White Paper on recent issues in bioanalysis: focus on biomarker assay validation (BAV): (Part 3 - LBA, biomarkers and immunogenicity).

Sam H Haidar, Gustavo Mendes Lima Santos, Sam H. Haidar, 2016, Bioanalysis.

Prandial ghrelin attenuation provides evidence that des-acyl ghrelin may be an artifact of sample handling in human plasma.

S. Fraser, Mark Dysinger, M. Blatnik, 2012, Bioanalysis.

Ultra-Sensitive Measurement of IL-17A and IL-17F in Psoriasis Patient Serum and Skin

H. Valdez, S. Fraser, L. Fitz, 2017, The AAPS Journal.

Recommendations for the evaluation of specimen stability for flow cytometric testing during drug development.

Virginia Litwin, Yuanxin Xu, Stephanie Fraser, 2015, Journal of immunological methods.

2018 White Paper on Recent Issues in Bioanalysis: focus on flow cytometry, gene therapy, cut points and key clarifications on BAV (Part 3 - LBA/cell-based assays: immunogenicity, biomarkers and PK assays).

Neil Henderson, Rong Zeng, Renuka Pillutla, 2018, Bioanalysis.

Quantitative analysis of four protein biomarkers: An automated microfluidic cartridge-based method and its comparison to colorimetric ELISA.

Stephanie Fraser, Mark Dysinger, S. Fraser, 2017, Journal of immunological methods.

2018 White Paper on Recent Issues in Bioanalysis: focus on immunogenicity assays by hybrid LBA/LCMS and regulatory feedback (Part 2 - PK, PD & ADA assays by hybrid LBA/LCMS & regulatory agencies' inputs on bioanalysis, biomarkers and immunogenicity).

Eric Woolf, Akiko Ishii-Watabe, Naidong Weng, 2018, Bioanalysis.

Active glucagon-like peptide 1 quantitation in human plasma: a comparison of multiple ligand binding assay platforms.

Stephanie Fraser, Max Kuhn, Mark Dysinger, 2014, Journal of immunological methods.

Next Generation Ligand Binding Assays—Review of Emerging Real-Time Measurement Technologies

S. Fraser, M. Schwickart, M. Tanen, 2014, AAPS Journal.

Current Trends in Ligand Binding Real-Time Measurement Technologies

Mark Ware, Stephanie Fraser, Judy Y Shih, 2017, The AAPS Journal.

2015 White Paper on recent issues in bioanalysis: focus on new technologies and biomarkers (Part 3--LBA, biomarkers and immunogenicity).

Renuka Pillutla, Viswanath Devanarayan, An Song, 2015, Bioanalysis.

2013 White Paper on recent issues in bioanalysis: 'hybrid'--the best of LBA and LCMS.

Stacy Ho, Roger Hayes, Eric Woolf, 2013, Bioanalysis.

2014 White Paper on recent issues in bioanalysis: a full immersion in bioanalysis (Part 3 - LBA and immunogenicity).

Lindsay King, Roger Hayes, Surinder Kaur, 2014, Bioanalysis.